Centene Corporation (NYSE:CNC) – Investment analysts at Oppenheimer issued their Q4 2019 earnings per share (EPS) estimates for Centene in a research report issued to clients and investors on Tuesday. Oppenheimer analyst M. Wiederhorn anticipates that the company will post earnings per share of $1.53 for the quarter. Oppenheimer has a “Outperform” rating and a $122.00 price target on the stock.
Centene (NYSE:CNC) last posted its earnings results on Tuesday, October 24th. The company reported $1.35 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.11. The firm had revenue of $11.90 billion during the quarter, compared to the consensus estimate of $11.75 billion. Centene had a net margin of 1.81% and a return on equity of 14.79%. The company’s revenue was up 9.7% on a year-over-year basis. During the same quarter last year, the company earned $1.12 earnings per share.
Centene (NYSE CNC) traded down $0.35 on Thursday, hitting $111.00. 1,078,375 shares of the stock traded hands, compared to its average volume of 1,400,000. The stock has a market capitalization of $19,150.00, a P/E ratio of 22.93, a price-to-earnings-growth ratio of 1.35 and a beta of 0.70. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.99 and a quick ratio of 0.99. Centene has a 52-week low of $61.37 and a 52-week high of $111.76.
In other Centene news, Director Robert K. Ditmore sold 8,750 shares of Centene stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $104.30, for a total transaction of $912,625.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Jesse N. Hunter sold 10,000 shares of Centene stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $98.73, for a total transaction of $987,300.00. The disclosure for this sale can be found here. Insiders sold 27,917 shares of company stock valued at $2,777,255 over the last 90 days. 3.00% of the stock is owned by company insiders.
Institutional investors have recently made changes to their positions in the business. Mckinley Capital Management LLC Delaware bought a new stake in Centene during the second quarter valued at approximately $101,000. Baldwin Brothers Inc. MA bought a new stake in Centene during the third quarter valued at approximately $185,000. Calamos Advisors LLC bought a new stake in Centene during the third quarter valued at approximately $207,000. Commerzbank Aktiengesellschaft FI bought a new stake in Centene during the third quarter valued at approximately $207,000. Finally, Brown Advisory Inc. bought a new stake in Centene during the third quarter valued at approximately $226,000. Institutional investors and hedge funds own 92.16% of the company’s stock.
Centene Company Profile
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.